Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pharmthera.2020.107613 http://scihub22266oqcxt.onion/10.1016/j.pharmthera.2020.107613 32562826!ä!32562826 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pharmacol+Ther 2020 ; 214 (ä): 107613 Nephropedia Template TP {{tp|p=32562826|t=2020. Therapeutic potential of resveratrol against emerging respiratory viral infections |pdf=|usr=}}{{32562826}} gab.com Text Therapeutic potential of resveratrol against emerging respiratory viral infections JO: Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32562826 #FOAvip Resveratrol has been widely studied for its therapeutic potential due to its antioxidant, anti-inflammatory and anti-microbial properties. In particular, resveratrol has shown promising antiviral activity against numerous viruses responsible for severe respiratory infections. Amongst these, influenza virus, respiratory syncytial virus and the emerging SARS-cov-2 are known to cause pneumonia, acute respiratory distress syndrome or multi-organ failure, especially, in vulnerable individuals like immunocompromised patients or the elderly, leading to a considerable economic burden worldwide. In this context, resveratrol may have potential value for its anti-inflammatory activity, since most of the severe virus-associated complications are related to the overactivation of the host-immune response, leading to lung damage. Herein, we present an overview of the antiviral activity and potential mechanisms of resveratrol against the respiratory tract viruses considered as a public threat for their rapid transmission and high morbidity and mortality in the general population. Twit Text FOAVip Therapeutic potential of resveratrol against emerging respiratory viral infections ????Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32562826 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32562826 #FOAvip English Wikipedia <ref>{{Cite pmid|32562826}}</ref> Therapeutic potential of resveratrol against emerging respiratory viral infections #MMPMID32562826 Filardo S; Di Pietro M; Mastromarino P; Sessa R Pharmacol Ther 2020[Oct]; 214 (ä): 107613 PMID32562826show ga Resveratrol has been widely studied for its therapeutic potential due to its antioxidant, anti-inflammatory and anti-microbial properties. In particular, resveratrol has shown promising antiviral activity against numerous viruses responsible for severe respiratory infections. Amongst these, influenza virus, respiratory syncytial virus and the emerging SARS-cov-2 are known to cause pneumonia, acute respiratory distress syndrome or multi-organ failure, especially, in vulnerable individuals like immunocompromised patients or the elderly, leading to a considerable economic burden worldwide. In this context, resveratrol may have potential value for its anti-inflammatory activity, since most of the severe virus-associated complications are related to the overactivation of the host-immune response, leading to lung damage. Herein, we present an overview of the antiviral activity and potential mechanisms of resveratrol against the respiratory tract viruses considered as a public threat for their rapid transmission and high morbidity and mortality in the general population. |Antiviral Agents/pharmacokinetics/*pharmacology/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Communicable Diseases, Emerging/drug therapy[MESH] |Coronavirus Infections/drug therapy[MESH] |Humans[MESH] |Influenza, Human/drug therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/drug therapy[MESH] |Respiratory Syncytial Virus Infections/drug therapy[MESH] |Respiratory Tract Infections/*drug therapy/virology[MESH] |Resveratrol/pharmacokinetics/*pharmacology/*therapeutic use[MESH] |SARS-CoV-2[MESH]Therapeutic potential of resveratrol against emerging respiratory vira(epmc).pdf DeepDyve Pubget Overpricing